|
The website domain reflects its role for my own purpose only. Viewing of the webpages by others is not approved.
|
|
--- |
Myocardial Infarction
|
Warfarin for Secondary PreventionA number of studies have examined the use of warfarin for secondary prevention. In some studies “low-dose warfarin” plus low dose aspirin was compared with aspirin alone. Other studies compared “theurapeutic” dose warfarin plus aspirin with aspirin alone. Warfarin has also been compared directly with low dose aspirin. The conclusions that have been reached regarding use of warfarin for secondary prevention are:
The use of warfarin for secondary prevention has not been widely accepted, presumably because of the need for regular monitoring and the increased risk of bleeding. However, we should consider the use of warfarin plus low dose aspirin in some high risk patients who continue to have events despite use of all appropriate secondary prevention measures. Hitesh Patel, Cardiologist5th June, 2004
References: Users should read this document on "copyright" and "conditions of use". |
  |